Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LRMR | LYEL | FDMT | ||
| Company | Larimar Therapeutics Inc | Lyell Immunopharma Inc | 4D Molecular Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.40 | 19.62 | 8.79 | ||
| High | 4.65 | 20.67 | 9.48 | ||
| Low | 4.40 | 19.53 | 8.79 | ||
| Latest | 4.50 | 20.06 | 9.31 | ||
| Change | +0.19 | +0.77 | +0.74 | ||
| % Change | +4.41% | +3.99% | +8.63% | ||
| Volume | 1,750,900 | 112,400 | 705,100 | ||
| 20-Day Average Volume | 2,249,560 | 102,550 | 757,185 | ||
| Previous Close | 4.31 | 19.29 | 8.57 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.81 | 21.52 | 8.89 | ||
| 20-Day Raw Stochastic | 16.67% | 26.13% | 49.18% | ||
| 20-Day Relative Strength | 51.12 | 42.68 | 52.18 | ||
| Weighted Alpha | +27.93 | +12.83 | +118.67 | ||
| Today's Opinion | 88% Buy | 24% Sell | 40% Buy | ||
| Previous Opinion | 88% Buy | 24% Sell | 24% Sell | ||
| Last Month's Opinion | 56% Buy | 56% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.53% since 03/24/26 | +1.83% since 03/24/26 | +1.42% since 03/24/26 | ||
| Low | 4.21 on 03/30/26 | 18.30 on 03/27/26 | 8.45 on 03/30/26 | ||
| High | 4.85 on 03/26/26 | 21.20 on 03/25/26 | 10.70 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -15.25% since 02/27/26 | -16.42% since 02/27/26 | -3.62% since 02/27/26 | ||
| Low | 4.20 on 03/19/26 | 17.34 on 03/23/26 | 7.96 on 03/09/26 | ||
| High | 6.00 on 03/10/26 | 27.75 on 03/10/26 | 10.70 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | +14.50% since 12/26/25 | -42.83% since 12/26/25 | +16.81% since 12/26/25 | ||
| Low | 2.71 on 02/23/26 | 17.34 on 03/23/26 | 6.96 on 01/05/26 | ||
| High | 6.42 on 02/25/26 | 37.00 on 12/29/25 | 10.70 on 03/26/26 | ||
| 6-Month | |||||
| %Chg | -11.68% since 09/26/25 | +56.35% since 09/26/25 | +10.97% since 09/26/25 | ||
| Low | 2.71 on 02/23/26 | 12.68 on 09/29/25 | 6.96 on 01/05/26 | ||
| High | 6.42 on 02/25/26 | 45.00 on 12/22/25 | 12.34 on 10/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 447,736 | 449,592 | 437,507 | ||
| Shares Outstanding, K | 103,883 | 23,307 | 51,051 | ||
| Annual Sales | 0 | 40,000 | 85,210,000 | ||
| Annual Net Income | -165,670,000 | -274,450,000 | -140,110,000 | ||
| Last Quarter Sales | 0 | 10,000 | 85,090,000 | ||
| Last Quarter Net Income | -62,500,000 | -140,720,000 | 19,400,000 | ||
| 60-Month Beta | 0.90 | -0.14 | 2.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 03/19/26 | -7.68 on 03/12/26 | 0.43 on 03/18/26 | ||
| Latest Earnings Date | 04/29/26 | 05/12/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||